Arrowhead Research Corporation (ARWR) — Analysis Summary
Arrowhead Research Corporation (ARWR) has a market cap of $10.44B with year-over-year revenue growth of +23258.2%. Net margin stands at -0.2%. The stock trades at a P/E ratio of -34.7.
Key Takeaways
- Revenue changed +23258.2% year-over-year
- Net margin of -0.2%
- P/E ratio of -34.7
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ARWR posted revenue growth of +23258.2% and trades at a P/E of -34.7.
Arrowhead Research Corporation (ARWR)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -2.4x — earnings do not cover interest payments
Revenue fell 25.0% vs the prior period.
Operating margin at -35.7% — material operating losses
Net margin at -48.4% — significant losses
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
Sector
PHARMACEUTICAL PREPARATIONS
Employees
711
Headquarters
PASADENA, CA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.